This patent teaches the making of a serum free media for growth hematopoietic stem cells. Such a media is useful since the addition of fetal serum and especially fetal calf serum in culture medium for cell therapy is associated with regulatory hurdles.
Disclosed are culture conditions and compositions of matter that are useful for expansion of liver stem cells. This patent is useful not only for the generation of single cell hepatocytes, but may be used with other scaffold patents in order to generate artificial liver lobes.
This patent covers the use of hepatocyte growth factor (and various combinations) for the stimulation of hematopoietic stem cells.
This patent teaches ways of expanding neural stem cells without inducing loss of replicative ability. Specifically, this involves culture with one or more growth factors selected from a group comprising of EGF, amphiregulin, FGF-1, FGF-2 and TGF-beta.
This patent teaches the in vivo expansion of neural stem cells through administration of fibroblast growth factor in combination with an agent selected from the group comprising of: EGF, TGF, and amphiregulin. This patent is useful for the treatment of degenerative nervous system diseases alone, or in combination with exogenously administered stem cells.
This patent covers a type of neural stem cell that can differentiate into neurons and neuron supporting cells. This patent also teaches ways of expanding and differentiating the neural stem cells.
This patent covers neural stem cells of a specific phenotype and their use for delivery of gene products into an area of need.
The stem cells that generate T cells originate in the bone marrow and differentiate in the thymus. This patent teaches that T cell precursors can be expanded in high oxygen conditions in a thymic-like microenvironment. This patent is very interesting not only from the point of view of generating T cells for immune stimulation, but also because theoretically it can be applied to the generation...
Anyone performing autologous hematopoietic stem cell transplants should watch out for this patent !! This patent teaches essentially autologous transplantation with ex vivo expansion of stem cells. Numerous companies and scientists are doing or have done clinical investigations which potentially infringe on this patent.
This patent provide tissue culture reagents for the expansion of hematopoietic stem cells.